{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:11:48Z","timestamp":1760242308204,"version":"build-2065373602"},"reference-count":36,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T00:00:00Z","timestamp":1489968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The 1st Workshop of the Canadian Society for Virology (CSV2016) was a Special Workshop of the 35th Annual Meeting for the American Society for Virology, held on 18 June 2016 on the beautiful Virginia Tech campus in Blacksburg, Virginia. The workshop provided a forum for discussion of recent advances in the field, in an informal setting conducive to interaction with colleagues. CSV2016 featured two internationally-renowned Canadian keynote speakers who discussed translational virology research; American Society for Virology President Grant McFadden (then from University of Florida, now relocated to Arizona State University) who presented his studies of oncolytic poxviruses, while Matthew Miller (McMaster University) reviewed the prospects for a universal influenza vaccine. The workshop also featured a variety of trainee oral and poster presentations, and a panel discussion on the topic of the future of the CSV and virus research in Canada.<\/jats:p>","DOI":"10.3390\/v9030054","type":"journal-article","created":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T11:39:09Z","timestamp":1490009949000},"page":"54","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["1st Workshop of the Canadian Society for Virology"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2794-3722","authenticated-orcid":false,"given":"Craig","family":"McCormick","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, Dalhousie University, 5850 College Street, Halifax, NS B3H 4R2, Canada"},{"name":"Beatrice Hunter Cancer Research Institute, Dalhousie University, 5850 College Street, Halifax, NS B3H 4R2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9199-9654","authenticated-orcid":false,"given":"Nathalie","family":"Grandvaux","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Biochimie et M\u00e9decine Mol\u00e9culaire, Universit\u00e9 de Montr\u00e9al, QC H3C 3J7, Canada"},{"name":"Centre de Recherche du CHUM (CRCHUM), Montr\u00e9al, QC H2X 0A9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2017,3,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1462-5822.2004.00423.x","article-title":"Technical knockout: Understanding poxvirus pathogenesis by selectively deleting viral immunomodulatory genes","volume":"6","author":"Johnston","year":"2004","journal-title":"Cell Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1038\/leu.2009.219","article-title":"Myxoma virus targets primary human leukemic stem and progenitor cells while sparing normal hematopoietic stem and progenitor cells","volume":"23","author":"Kim","year":"2009","journal-title":"Leukemia"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.bbmt.2012.04.004","article-title":"Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virus","volume":"18","author":"Bartee","year":"2012","journal-title":"Biol. Blood Marrow Transp."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Bartee, E., Meacham, A., Wise, E., Cogle, C.R., and McFadden, G. (2012). Virotherapy using myxoma virus prevents lethal graft-versus-host disease following xeno-transplantation with primary human hematopoietic stem cells. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0043298"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1182\/blood-2014-07-587329","article-title":"Myxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cells","volume":"125","author":"Villa","year":"2015","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1159\/000360764","article-title":"Sustained activation of interferon regulatory factor 3 during infection by paramyxoviruses requires MDA5","volume":"6","author":"Grandvaux","year":"2014","journal-title":"J. Innate Immun."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1128\/JVI.00142-10","article-title":"Respiratory syncytial virus-mediated NF-kappa B p65 phosphorylation at serine 536 is dependent on RIG-I, TRAF6, and IKK beta","volume":"84","author":"Yoboua","year":"2010","journal-title":"J. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.it.2016.10.008","article-title":"Post-translational Control of Intracellular Pathogen Sensing Pathways","volume":"38","author":"Chiang","year":"2017","journal-title":"Trends Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1126\/science.1113329","article-title":"Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA","volume":"309","author":"Jopling","year":"2005","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1128\/JVI.02046-10","article-title":"Human Ago2 is required for efficient microRNA 122 regulation of hepatitis C virus RNA accumulation and translation","volume":"85","author":"Wilson","year":"2011","journal-title":"J. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.aad1283","article-title":"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels","volume":"351","author":"Haagmans","year":"2016","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3201\/eid2012.141280","article-title":"Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels","volume":"20","author":"Adney","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3201\/eid2206.152113","article-title":"MERS-CoV Infection of Alpaca in a Region Where MERS-CoV is Endemic","volume":"22","author":"Reusken","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3201\/eid2002.131182","article-title":"Replicative Capacity of MERS Coronavirus in Livestock Cell Lines","volume":"20","author":"Eckerle","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Border\u00eda, A.V., Isakov, O., Moratorio, G., Henningsson, R., Ag\u00fcera-Gonz\u00e1lez, S., Organtini, L., Gn\u00e4dig, N.F., Blanc, H., Alcover, A., and Hafenstein, S. (2015). Group Selection and Contribution of Minority Variants during Virus Adaptation Determines Virus Fitness and Phenotype. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004838"},{"key":"ref_16","first-page":"303","article-title":"Fidelity Variants and RNA Quasispecies","volume":"392","author":"Vignuzzi","year":"2016","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1053\/j.gastro.2014.07.005","article-title":"Signatures of protective memory immune responses during hepatitis C virus reinfection","volume":"147","author":"Murphy","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Abdel-Hakeem, M.S., Boisvert, M., Bruneau, J., Soudeyns, H., and Shoukry, N.H. (2017). Selective expansion of high functional avidity memory CD8 T cell clonotypes during hepatitis C virus reinfection and clearance. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006191"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Dirk, B.S., Jacob, R.A., Johnson, A.L., Pawlak, E.N., Cavanagh, P.C., Van Nynatten, L., Haeryfar, S.M.M., and Dikeakos, J.D. (2015). Viral bimolecular fluorescence complementation: A novel tool to study intracellular vesicular trafficking pathways. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0125619"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"37021","DOI":"10.1038\/srep37021","article-title":"HIV-1 Nef sequesters MHC-I intracellularly by targeting early stages of endocytosis and recycling","volume":"6","author":"Dirk","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Saeed, M.F., Kolokoltsov, A.A., Albrecht, T., and Davey, R.A. (2010). Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1001110"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature10348","article-title":"Ebola virus entry requires the cholesterol transporter Niemann-Pick C1","volume":"477","author":"Carette","year":"2011","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature10380","article-title":"Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection","volume":"477","author":"Misasi","year":"2011","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.virol.2011.08.009","article-title":"The Ebola virus glycoprotein mediates entry via a non-classical dynamin-dependent macropinocytic pathway","volume":"419","author":"Mulherkar","year":"2011","journal-title":"Virology"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Miller, M.S., Gardner, T.J., Krammer, F., Aguado, L.C., Tortorella, D., Basler, C.F., and Palese, P. (2013). Neutralizing antibodies against previously encountered influenza virus strains increase over time: A longitudinal analysis. Sci. Transl. Med., 5.","DOI":"10.1126\/scitranslmed.3006637"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/infdis\/jis652","article-title":"1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans","volume":"207","author":"Miller","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"13133","DOI":"10.1073\/pnas.1414070111","article-title":"Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans","volume":"111","author":"Ellebedy","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.coi.2016.05.012","article-title":"Heads, stalks and everything else: How can antibodies eradicate influenza as a human disease","volume":"42","author":"Neu","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1128\/JVI.03099-14","article-title":"Broadly neutralizing anti-influenza virus antibodies: Enhancement of neutralizing potency in polyclonal mixtures and IgA backbones","volume":"89","author":"He","year":"2015","journal-title":"J. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"11931","DOI":"10.1073\/pnas.1609316113","article-title":"Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus","volume":"113","author":"He","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3389\/fmicb.2015.01119","article-title":"Amdoparvoviruses in small mammals: Expanding our understanding of parvovirus diversity, distribution, and pathology","volume":"6","author":"Canuti","year":"2015","journal-title":"Front Microbiol."},{"key":"ref_32","unstructured":"Canuti, M., Doyle, H.E., Britton, A., and Lang, A.S. Full genetic characterization and epidemiology of a novel amdoparvovirus in striped skunk (Mephitis mephitis), Emerg. Microbes Infect., in press."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Canuti, M., O\u2019Leary, K.E., Hunter, B.D., Spearman, G., Ojkic, D., Whitney, H.G., and Lang, A.S. (2016). Driving forces behind the evolution of the Aleutian mink disease parvovirus in the context of intensive farming. Virus Evol., 2.","DOI":"10.1093\/ve\/vew004"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-065X.2010.00977.x","article-title":"Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses","volume":"239","author":"Houghton","year":"2011","journal-title":"Immunol. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Law, J.L., Chen, C., Wong, J., Hockman, D., Sante, D.M., Frey, S.E., Belshe, R.B., Wakita, T., Bukh, J., and Jones, C.T. (2013). A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1\/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059776"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"14278","DOI":"10.1128\/JVI.01911-14","article-title":"Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization","volume":"88","author":"Wong","year":"2014","journal-title":"J. Virol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/9\/3\/54\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:30:49Z","timestamp":1760207449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/9\/3\/54"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,20]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3]]}},"alternative-id":["v9030054"],"URL":"https:\/\/doi.org\/10.3390\/v9030054","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2017,3,20]]}}}